Total Holdings
33
Portfolio diversification across 33 positions
PJP
(NYSEARCA)Invesco Pharmaceuticals ETF
$114.09-- (--)
Loading... - Market loading
PJP ETF Holdings: Invesco Pharmaceuticals ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$344.33M
Total fund assets
Expense Ratio
0.57%
Annual management fee
Fund Issuer
Invesco
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 29 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 5.42% |
| 2 |  | AbbVie Inc | Stock | 5.34% |
| 3 |  | Abbott Laboratories | Stock | 5.31% |
| 4 |  | Amgen Inc. | Stock | 5.22% |
| 5 |  | Johnson & Johnson | Stock | 5.19% |
| 6 |  | Merck & Co., Inc | Stock | 5.04% |
| 7 |  | Pfizer Inc. | Stock | 5.03% |
| 8 |  | Gilead Sciences, Inc | Stock | 4.73% |
| 9 |  | Corcept Therapeutics Incorporated | Stock | 3.87% |
| 10 |  | Amneal Pharmaceuticals, Inc. | Stock | 3.57% |
| 11 |  | Travere Therapeutics, Inc. | Stock | 3.42% |
| 12 |  | Liquidia Corporation | Stock | 3.36% |
| 13 |  | Harmony Biosciences Holdings Inc | Stock | 3.22% |
| 14 |  | Ocular Therapeutix, Inc. | Stock | 3.05% |
| 15 |  | Ligand Pharmaceuticals Incorporated | Stock | 3.03% |
| 16 |  | Perrigo Company plc | Stock | 2.94% |
| 17 |  | Biogen Inc | Stock | 2.93% |
| 18 |  | Collegium Pharmaceutical Inc | Stock | 2.89% |
| 19 |  | Prestige Consumer Healthcare Inc | Stock | 2.88% |
| 20 |  | Tarsus Pharmaceuticals Inc | Stock | 2.86% |
| 21 |  | ANI Pharmaceuticals, Inc. | Stock | 2.84% |
| 22 |  | Viatris Inc | Stock | 2.83% |
| 23 |  | Innoviva, Inc | Stock | 2.82% |
| 24 |  | Bristol-Myers Squibb Company | Stock | 2.76% |
| 25 |  | Regeneron Pharmaceuticals, Inc | Stock | 2.76% |
| 26 |  | Jazz Pharmaceuticals plc | Stock | 2.74% |
| 27 |  | United Therapeutics Corporation | Stock | 2.71% |
| 28 |  | Supernus Pharmaceuticals, Inc | Stock | 2.71% |
| 29 | N NMFQS:AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | Cash | 0.04% |
Frequently Asked Questions About Invesco Pharmaceuticals ETF Holdings
What are the top holdings in PJP?
Invesco Pharmaceuticals ETF (PJP) holds 33 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is PJP's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review PJP's holdings table to analyze concentration risk.
What is PJP's sector allocation?
The Sector Allocation chart shows how PJP distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does PJP invest in?
PJP's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is PJP ETF?
PJP's diversification can be assessed by reviewing its 33 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.